Patents by Inventor Stephen John Carter

Stephen John Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6984725
    Abstract: In accordance with the present invention there is provided a method for the separation of a triglycoalkaloid in which the triglycoside portion comprises ?-L-rhamnopyranosyl-(1?2gal)-O-?-D-glucopyranosyl-(1?3gal)-?-D-galactopyranose (or 6-deoxy-?-L-mannopyranosyl-(1?2)-O-[?-D-glucopyranosyl-(1?3)]-?-D-galactopyranoside) (‘an rhamnose-glucose-galactose triglycoalkaloid’) from a triglycoalkaloid in which the triglycoside portion is ?-L-rhamnopyranosyl-(1?2glu)-O-?-L-rhamnopyranosyl-(1?4glu)-?-D-glucopyranose (‘a rhamnose-rhamnose-glucose triglycoalkaloid’) in a mixture containing both, the method comprising the steps of: Combining the mixture with a portion of alcoholic solvent; Causing or allowing a substantial portion of the rhamnose-rhamnose-glucose triglycoalkaloid to dissolve, thereby generating an alcoholic solution substantially of the rhamnose-rhamnose-glucose triglycoalkaloid, and a solid substantially comprising the rhamnose-glucose-galactose triglycoalkaloid; and Separating the solid substantially com
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: January 10, 2006
    Assignee: Solbec Pharmaceuticals Ltd.
    Inventors: Stephen John Carter, Paul Edward Murray, John Edward Parkin, Gautam Dalwadi
  • Patent number: 6930171
    Abstract: An isolated RBP with at least one of the following characteristics: a) a molecular weight of approximately 65-70 kDa and more preferably 66-69 kDa; b) a pl of greater than 10 or less than 3; c) a dissociation constant of approximately 1.5×10?6 when bound to the rhamnose moiety of solamargine; d) adapted to bind to a rhamnose affinity column prepared according to example 1 and under the conditions set out therein; e) adapted to be eluted from the column in example 1 with a 100 mM rhamnose solution; f) insoluble in aqueous solution; and g) soluble in highly denaturing buffers containing greater that approximately 2% surfactant.
    Type: Grant
    Filed: February 7, 2003
    Date of Patent: August 16, 2005
    Assignee: Solbec Pharmaceuticals Limited
    Inventors: Richard J. Lipscombe, Stephen John Carter, Michael Ruane
  • Publication number: 20040053857
    Abstract: A composition comprising at least two glycoalkaloids of formula I: 1
    Type: Application
    Filed: June 27, 2003
    Publication date: March 18, 2004
    Applicant: SOLBEC PHARMACEUTICALS LIMITED
    Inventors: Stephen John Carter, Elizabeth Williams
  • Publication number: 20040030109
    Abstract: In accordance with the present invention there is provided a method for the separation of a triglycoalkaloid in which the triglycoside portion comprises &agr;-L-rhamnopyranosyl-(1→2gal)-O-&bgr;-D-glucopyranosyl-(1→3gal)-&bgr;-D-galactopyranose (or 6-deoxy-&agr;-L-mannopyranosyl-(1→2)-O-[&bgr;-D-glucopyranosyl-(1→3)]-&bgr;-D-galactopyranoside) (‘an rhamnose-glucose-galactose triglycoalkaloid’) from a triglycoalkaloid in which the triglycoside portion is &agr;-L-rhamnopyranosyl-(1→2glu)-O-&agr;-L-rhamnopyranosyl-(1→4glu)-&bgr;-D-glucopyranose (‘a rhamnose-rhamnose-glucose triglycoalkaloid’) in a mixture containing both, the method comprising the steps of:
    Type: Application
    Filed: June 13, 2003
    Publication date: February 12, 2004
    Applicant: SOLBEC PHARMACEUTICALS LTD.
    Inventors: Stephen John Carter, Paul Edward Murray, John Edward Parkin, Gautam Dalwadi
  • Publication number: 20040030104
    Abstract: An isolated RBP with at least one of the following characteristics:
    Type: Application
    Filed: February 7, 2003
    Publication date: February 12, 2004
    Applicant: SOLBEC PHARMACEUTICALS LIMITED
    Inventors: Richard J. Lipscombe, Stephen John Carter, Michael Ruane